1 |
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
DOI
ScienceOn
|
2 |
Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386-392
DOI
ScienceOn
|
3 |
Cho MJ, Kim JK, Jeon HJ, Suh T, Chung IW, Hong JP, et al. Lifetime and 12-month prevalence of DSMIV psychiatric disorders among Korean adults. J Nerv Ment Dis 2007;195:203-210.
DOI
ScienceOn
|
4 |
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-858.
DOI
ScienceOn
|
5 |
Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord 1997;43:27-39.
DOI
ScienceOn
|
6 |
Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992;149:795-800.
DOI
|
7 |
Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998;55:1128-1132.
DOI
ScienceOn
|
8 |
Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992;305:1198-1202.
DOI
ScienceOn
|
9 |
Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47:1093-1099.
DOI
ScienceOn
|
10 |
Delgado PL. Approaches to the enhancement of patient adherence to antidepressant medication treatment. J Clin Psychiatry 2000;61:6-9.
|
11 |
Colom F, Vieta E. Non-adherence in psychiatric disorders: misbehaviour or clinical feature? Acta Psychiatr Scand 2002;105:161-163.
DOI
ScienceOn
|
12 |
Katon W, von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992;30:67-76.
DOI
ScienceOn
|
13 |
Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006;163:101-108.
DOI
ScienceOn
|
14 |
Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998;49:196-201.
DOI
|
15 |
Simon GE, VonKorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 1993;15:399-408.
DOI
ScienceOn
|
16 |
Lin EH, Von Korff M, Katon W, Bush T, Simon GE, Walker E, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 1995;33:67-74.
DOI
ScienceOn
|
17 |
Dunn RL, Donoghue JM, Ozminkowski RJ, Stephenson D, Hylan TR. Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. J Psychopharmacol 1999;13:136-143.
DOI
ScienceOn
|
18 |
Lee KU, Kim W, Min KJ, Shin YC, Chung SK, Bahk WM. The rate and risk factors of early discontinuation of antidepressant treatment in patients with major depressive disorder. Korean J Psychopharmacol 2006;17:550-556.
|
19 |
Kim NS, Kim KH, Lee SM, Paik JW, Lee BR, Hwang JH. Health services utilization and depression care quality among depressed patients. Seoul: Health insurance review and assessment service;2008.
|
20 |
Keith SJ, Kane JM. Partial compliance and patient consequences in schizophrenia: our patients can do better. J Clin Psychiatry 2003;64:1308-1315.
DOI
ScienceOn
|
21 |
Haynes R, Taylor D, Sackett D. Compliance in Health Care. baltimore: Johns Hopkins University Press;1979.
|
22 |
Frank E, Perel JM, Mallinger AG, Thase ME, Kupfer DJ. Relationship of pharmacologic compliance to longterm prophylaxis in recurrent depression. Psychopharmacol Bull 1992;28:231-235
|
23 |
Demyttenaere K, Enzlin P, Dewe W, Boulanger B, De Bie J, De Troyer W, et al. Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. J Clin Psychiatry 2001;62:30-33.
DOI
ScienceOn
|
24 |
Byrne N, Regan C, Livingston G. Adherence to treatment in mood disorders. Curr Opin Psychiatry 2006;19:44-49.
DOI
ScienceOn
|
25 |
George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2000;50:166-171.
DOI
ScienceOn
|
26 |
Kruse W, Weber E. Dynamics of drug regimen compliance-its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990;38:561-565.
DOI
ScienceOn
|
27 |
Kim JB. A Cognitive Therapy Approach to Enhance Medication Compliance(in Korean). J Korean Society of Biological Therapies in Psychiatry 2002;8:34-39.
|
28 |
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74
DOI
ScienceOn
|
29 |
Kim SW, Kim MY, Yoo TW, Huh BR. Concurrent validity of the Korean version of self-reported questionnaire (in Korean). J Korean Acad Fam Med 1995;16:172-180.
|
30 |
Byerly M, Fisher R, Whatley K, Holland R, Varghese F, Carmody T, et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 2005;133:129-133.
DOI
ScienceOn
|
31 |
Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ 1996;312:345-349.
DOI
ScienceOn
|
32 |
Park MC. Psychodynamic Approach for Adherence(in Korean). J Korean Society of Biological Therapies in Psychiatry 2002;8:40-45.
|
33 |
Blackwell B. Treatment adherence. Br J Psychiatry 1976;129:513-531.
DOI
ScienceOn
|
34 |
Tasman A, Riba MB, Silk KR. The doctor-patient relationship in pharmacotherapy: improving treatment effectiveness. New York: The Guilford Press;2000.
|
35 |
Fawcett J. Compliance: definitions and key issues. J Clin Psychiatry 1995;56:4-8.
|
36 |
Kaplan EM. Antidepressant noncompliance as a factor in the discontinuation syndrome. J Clin Psychiatry 1997;58:31-35.
|
37 |
Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv 2001;52:1615-1620.
DOI
ScienceOn
|
38 |
Judge R. Patient perspectives on once-weekly fluoxetine. J Clin Psychiatry 2001;62:53-57.
|
39 |
de Craen AJ, Roos PJ, Leonard de Vries A, Kleijnen J. Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness. BMJ 1996;313:1624-1626.
DOI
ScienceOn
|
40 |
Buckalew LW, Coffield KE. An investigation of drug expectancy as a function of capsule color and size and preparation form. J Clin Psychopharmacol 1982;2:245-248.
|
41 |
Boyle E, Chambers M. Medication compliance in older individuals with depression: gaining the views of family carers. J Psychiatr Ment Health Nurs 2000;7:515-522.
DOI
ScienceOn
|
42 |
Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-845.
DOI
ScienceOn
|
43 |
Cohen NL, Ross EC, Bagby RM, Farvolden P, Kennedy SH. The 5-factor model of personality and antidepressant medication compliance. Can J Psychiatry 2004;49:106-113
DOI
|
44 |
Frank E, Kupfer DJ, Siegel LR. Alliance not compliance: a philosophy of outpatient care. J Clin Psychiatry 1995;56:11-16.
|
45 |
Ekselius L, Bengtsson F, von Knorring L. Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality. Int Clin Psychopharmacol 2000;15:273-278.
DOI
ScienceOn
|
46 |
Book HE. Some psychodynamics of non-compliance. Can J Psychiatry 1987;32:115-117.
DOI
|
47 |
DiMatteo MR, Sherbourne CD, Hays RD, Ordway L, Kravitz RL, McGlynn EA, et al. Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol 1993;12:93-102.
DOI
|
48 |
Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995;273:1026-1031.
DOI
ScienceOn
|
49 |
Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996;53:924-932.
DOI
ScienceOn
|
50 |
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-2879.
DOI
ScienceOn
|
51 |
Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ 1999;319:612-615.
DOI
ScienceOn
|
52 |
Bollini P, Pampallona S, Kupelnick B, Tibaldi G, Munizza C. Improving compliance in depression: a systematic review of narrative reviews. J Clin Pharm Ther 2006;31:253-260.
DOI
ScienceOn
|